LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement

BACKGROUND: Lymphocyte antigen 6 complex, locus K (LY6K) is a putative oncogene in various cancers. Elevated expression of LY6K is correlated with poor patient prognosis in glioblastoma (GBM). The aim of this study is to advance our understanding of the mechanism by which LY6K contributes to GBM tum...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Sastry, Namratha G, Wan, Xuechao, Huang, Tianzhi, Alvarez, Angel A, Pangeni, Rajendra P, Song, Xiao, James, Charles David, Horbinski, Craig M, Brennan, Cameron W, Nakano, Ichiro, Hu, Bo, Cheng, Shi-Yuan
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Basic and Translational Investigations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523463/
https://ncbi.nlm.nih.gov/pubmed/32055849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa032
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы